These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 370843)

  • 1. Structure and biological activity of heparin and other glycosaminoglycans.
    Casu B
    Pharmacol Res Commun; 1979 Jan; 11(1):1-18. PubMed ID: 370843
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulations of thrombin activity by polyelectrolytes in the presence of antithrombin III.
    Schiele J; Heuck CC
    Semin Thromb Hemost; 1991; 17 Suppl 1():35-41. PubMed ID: 2068569
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of heparin sulfate fractions on coagulation and hemostasis.
    Nader HB; Dietrich CP
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):504-8. PubMed ID: 4275736
    [No Abstract]   [Full Text] [Related]  

  • 4. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of sulfate content and degree of carboxylation of heparin and related glycosaminoglycans with anticomplement activity. Relationships to the anticoagulant and platelet-aggregating activities.
    Cofrancesco E; Radaelli F; Pogliani E; Amici N; Torri GG; Casu B
    Thromb Res; 1979 Jan; 14(1):179-87. PubMed ID: 570740
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of the collagen-binding of endogenous serum vitronectin by heating, urea and glycosaminoglycans.
    Ishikawa M; Hayashi M
    Biochim Biophys Acta; 1992 May; 1121(1-2):173-7. PubMed ID: 1376146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosaminoglycans and the control of cell surface proteinase activity.
    Long WF; Williamson FB
    Med Hypotheses; 1983 Jul; 11(3):285-308. PubMed ID: 6358810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical approaches to define the structure-activity relationship of heparin-like glycosaminoglycans.
    Noti C; Seeberger PH
    Chem Biol; 2005 Jul; 12(7):731-56. PubMed ID: 16039522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chemical and anticoagulant nature of heparin.
    Jaques LB; McDuffie NM
    Semin Thromb Hemost; 1978; 4(4):277-97. PubMed ID: 150031
    [No Abstract]   [Full Text] [Related]  

  • 10. [Interaction of aminasin and novocain with acid mucopolysaccharides and mucoproteins].
    Bychkov SM; Khazanova AI
    Vopr Med Khim; 1967; 13(5):491-8. PubMed ID: 4235110
    [No Abstract]   [Full Text] [Related]  

  • 11. Prolonged bleeding time induced by anticoagulant glycosaminoglycans in dogs is associated with the inhibition of thrombin-induced platelet aggregation.
    Kitazato K; Kitazato KT; Sasaki E; Minamiguchi K; Nagase H
    Thromb Res; 2003; 112(1-2):83-91. PubMed ID: 15013278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the interaction of heparin with thrombin, antithrombin, and other plasma proteins.
    Longas MO; Ferguson WS; Finlay TH
    Arch Biochem Biophys; 1980 Apr; 200(2):505-602. PubMed ID: 7436418
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physico-chemical characteristics of heparin in relation to its anticoagulant and anti-hemostatic action].
    Nader HB; Dietrich CP; Straus AH; Takahashi HK
    Rev Bras Biol; 1979 Nov; 39(4):793-816. PubMed ID: 162073
    [No Abstract]   [Full Text] [Related]  

  • 15. Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding.
    Wang H; Toida T; Kim YS; Capila I; Hileman RE; Bernfield M; Linhardt RJ
    Biochem Biophys Res Commun; 1997 Jun; 235(2):369-73. PubMed ID: 9199199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of biologic properties of a polysulfated chondroitin, A73025.
    Radhakrishnamurthy B; Godofsky A; Dalferes ER; Srinivasan S; Vijayagopal P; Berenson G
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):410-4. PubMed ID: 7413661
    [No Abstract]   [Full Text] [Related]  

  • 17. Heparin, antithrombin, and abnormal clotting.
    Rosenberg RD
    Annu Rev Med; 1978; 29():367-78. PubMed ID: 77142
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of 3',5'-cyclic AMP phosphodiesterase by acid mucopolysaccharides and sulfopolysaccharides.
    Stefanovich V
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):557-72. PubMed ID: 4363356
    [No Abstract]   [Full Text] [Related]  

  • 19. Probing the interaction of dengue virus envelope protein with heparin: assessment of glycosaminoglycan-derived inhibitors.
    Marks RM; Lu H; Sundaresan R; Toida T; Suzuki A; Imanari T; Hernáiz MJ; Linhardt RJ
    J Med Chem; 2001 Jun; 44(13):2178-87. PubMed ID: 11405655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new method for covalent coupling of heparin and other glycosaminoglycans to substances containing primary amino groups.
    Hoffman J; Larm O; Scholander E
    Carbohydr Res; 1983 Jun; 117():328-31. PubMed ID: 6883369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.